In this week’s roundup... Sexual and reproductive health survey, updated and digitised Disclosure of rape or sexual assault (SARCS) guidance, the new scanning centre is now fully operational at the Gyle, and your next prescription collection date is the Thursday 4th July 2024.
Your next Parcelforce prescription collection is coming up on Thursday, 4th July 2024.
Researchers from Edinburgh University and Sexual and Reproductive Health (SRH) have produced a Scottish Government-funded survey for community pharmacists about their practice around SRH in the community pharmacy.
This Circular advises community pharmacy contractors that the two UK-wide Serious Shortage Protocols (SSPs) for Clarithromycin antibiotic products due to expire on 21 June 2024 have now been extended until Friday 19 July 2024.
The Community Pharmacy Scotland Newsletter has now been released. If you qualify as an Associate Member and you would like the eNewsletter sent directly to your inbox every Thursday at 6:15pm, then please sign up.
The new scanning centre is now fully operational at the Gyle now, of which your Parcel Force bags are pre-labelled for.
CP IPs and trainees can check certificate details on TURAS. Details on the attachment below.
Our colleagues at the Scottish Government have asked us to disseminate the following information to pharmacy teams:
The following are the Top Three items currently under discussion and review by your CPS Board. There is no specific detail, yet, as these are currently “works in progress”. Further detail will follow as available.
This Circular advises Health Boards and community pharmacy contractors that a series of Public Health Service (PHS) poster campaigns is planned to be distributed to pharmacies over the course of 2024/25
Your next Parcelforce prescription collection is coming up on Thursday, 20th June 2024.
Here is the detail for a Podiatry Training which is offered for any community pharmacists who would like to attend. Details of how to apply to the organiser are in the invitation. CPS is supporting, but not sponsoring the event.
The University of Glasgow has launched a citizen science initiative for reporting mosquito sightings across Scotland. This aims to map mosquito distribution and species variety. Visit the reporting portal at www.mosquito-scotland.com. The blog post includes details on supporting the initiative with flyers, social media infographics, and shareable tweets. Your support in promoting this project is appreciated.
NSS have confirmed that the final cumulative statements have all been sent to contractors detailing information about payments received by contractors during the nDCVP implementation and resultant estimated payment process.
The Community Pharmacy Scotland Newsletter has now been released. If you qualify as an Associate Member and you would like the eNewsletter sent directly to your inbox every Thursday at 6:15pm, then please sign up.
Our colleagues at NHS National Services Scotland (NSS) have written to Independent Pharmacy Contractors to inform them about some issues that have arisen during the switchover to SWAN2.
The Psychotropic Drug Directory is now available to all users of NES Knowledge Network. Access to this has been funded by the Scottish Government’s Mental Health Directorate.
The Scottish Government are hosting a women's health lunchtime webinar on the 26th of June with Professor Martha Hickey on Empowering Woman to Manage Menopause.
Due to the day on which the 1st June falls this year, we will publish the June edition of Part 7 on the website slightly later than usual, on Monday 3rd May 2024.
In this week’s roundup... Our Policy & Development team bring you all the latest news affecting community pharmacy in Scotland including, Christine Grahame MSP’s visit to Lauder Pharmacy, Post-registration Foundation Programme 2024, Prescription Collection for the 4th June, Consultation on the Quality Assurance of Pharmacy Education and Training and the RPS Survey on Digital Systems Access in Community Pharmacy.
The Community Pharmacy Scotland Newsletter has now been released. If you qualify as an Associate Member and you would like the eNewsletter sent directly to your inbox every Thursday at 6:15pm, then please sign up.
This Circular advises Health Boards and community pharmacy contractors that the two UK-wide Serious Shortage Protocols (SSPs) for Clarithromycin 125mg/5ml and 250mg/5ml oral suspension have been reactivated on 22 May 2024. The new end date for both SSPs is now 21 June 2024.
To advise of a Serious Shortage Protocol (SSP) in place for Creon® 25000 gastro-resistant capsules, from 24 May 2024 to 22 November 2024.
To advise of a Serious Shortage Protocol (SSP) in place for Creon® 10000 gastro-resistant capsules, from 24 May 2024 to 22 November 2024.
This circular advises community pharmacy contractors and NHS Boards on the amendments to the Drug Tariff Part 11 clawback scale.
Information for pharmacists who may wish to join the programme in September 2024.
The RPS are running a survey looking into community pharmacists current experience of accessing digital records in practice and they want to understand what is needed to improve digital access for you and your patients.
Your next Parcelforce prescription collection is coming up on Tuesday, 4th June 2024.
To view our latest eNewsletter through your browser, please click on the link
Last week on Friday we met with MSP Christine Grahame at Lauder Pharmacy, in the Borders. hosted by prescribing pharmacists, Hilary Evans and Cathy Scaife.
This Circular advises community pharmacy contractors that the two UK-wide Serious Shortage Protocols (SSPs) for Clarithromycin antibiotic products due to expire on 21 June 2024 have now been extended until Friday 19 July 2024.
This Circular advises Health Boards and community pharmacy contractors that a series of Public Health Service (PHS) poster campaigns is planned to be distributed to pharmacies over the course of 2024/25
This Circular advises Health Boards and community pharmacy contractors that the two UK-wide Serious Shortage Protocols (SSPs) for Clarithromycin 125mg/5ml and 250mg/5ml oral suspension have been reactivated on 22 May 2024. The new end date for both SSPs is now 21 June 2024.
To advise of a Serious Shortage Protocol (SSP) in place for Creon® 25000 gastro-resistant capsules, from 24 May 2024 to 22 November 2024.
To advise of a Serious Shortage Protocol (SSP) in place for Creon® 10000 gastro-resistant capsules, from 24 May 2024 to 22 November 2024.
This circular advises community pharmacy contractors and NHS Boards on the amendments to the Drug Tariff Part 11 clawback scale.
This Circular advises NHS Boards and community pharmacy contractors that the UK-wide Serious Shortage Protocol (SSP) for isosorbide mononitrate (Monomil® XL) 60mg modified release tablet due to expire on 3 May 2024 has been extended until Friday 31 May 2024.
This Circular encloses new guidance for dispensing General Practises across Scotland.
To advise of a Serious Shortage Protocol (SSP) in place for isosorbide mononitrate (Monomil® XL) 60mg modified release tablet, from 26 March 2024 to 3 May 2024.
This Circular advises Health Boards and community pharmacy contractors of updated Patient Group Directions (PGDs) that are to be implemented for the treatment of shingles and skin infections under NHS Pharmacy First Scotland.
This Circular advises NHS Boards and healthcare professionals that print copies of the British National Formulary (BNF) and BNF for Children (BNFC) will no longer be provided
PCA(P)(2023)46 - Pharmaceutical Services Amendments To The Drug Tariff Part 11 Discount Clawback Scale
This Circular provides updated guidance aimed at both community optometry and community pharmacy teams and an updated referral form for the assessment and treatment of minor eye conditions.
This circular advises community pharmacy contractors and Health Boards of a corrective payment in order to deliver contractual requirements for the financial year 2023/24.
This Circular advises NHS Boards and community pharmacy contractors that the UK-wide Serious Shortage Protocol (SSP) for Clarithromycin
This circular informs NHS Boards and community pharmacy contractors of the intention to continue funding for Community Pharmacist Practitioner Champions in 2023-24.
This Circular advises NHS Boards and community pharmacy contractors that the UK-wide Serious Shortage Protocol (SSP) for Clarithromycin
This Circular advises NHS Boards and community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Estradot®
This Circular advises NHS Boards and community pharmacy contractors of the next Public Health Service (PHS) poster campaign topics which will be distributed to pharmacies.
This Circular advises NHS Boards and community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Jext® 300 micrograms/ 0.3mL (1 in 1000) solution for injection auto-injector pen
This Circular advises community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Estradot® (estradiol hemihydrate) 100 microgram patches
This Circular advises community pharmacy contractors that two of the UK-wide Serious Shortage Protocols (SSPs) for Clarithromycin antibiotic
This circular advises of changes to the Drug Tariff with respect to remuneration arrangements for the dispensing pool month of July.
Our colleagues at Scottish Government have published the following circular advising community pharmacy contractors and NHS Boards that a naloxone emergency supply service will be added to the community pharmacy Public Health Service from 30th of October 2023.
This Circular advises community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Estradot® (estradiol hemihydrate) 100 microgram patches
This Circular advises community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Utrogestan®
To advise of a Serious Shortage Protocol (SSP) in place for Jext® 300 micrograms/0.3mL (1 in 1000) solution for injection auto-injector pen, from 21 August 2023 to 15 September 2023.
To advise of a Serious Shortage Protocol (SSP) in place for Estradot® (Estradiol hemihydrate) 100 microgram patches, from 21 August 2023 to 8 September 2023.
This Circular advises community pharmacy contractors that the Serious Shortage Protocol (SSP) for Progynova®
This Circular advises community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Utrogestan® (micronised progesterone) 100mg capsules
The Scottish Government have updated the NHS Pharmacy First Approved List and to follow national prescribing guidance Simple Linctus sugar-free and Simple Linctus Paediatric sugar-free have now been removed from this list.
The update is to Section 10 Skin to remove Epimax Ointment and Epimax Paraffin free Ointment from NHS Grampian’s list only.
The NHS Pharmacy First Scotland Service approved list of products has been updated as of 1st of April 2024.
This Circular advises Health Boards and community pharmacy contractors of updated Patient Group Directions (PGDs) that are to be implemented for the treatment of shingles and skin infections under NHS Pharmacy First Scotland.
We have been working with Scottish Government and NHS colleagues on trying to capture Pharmacy First Plus prescribing, advice and referrals data to better evidence the great work being done out in the network – at the moment, this cannot be separated out from standard Pharmacy First activity.
As some of you may be aware, NHS England are due to launch the NHS Pharmacy First service in English community pharmacies on 31st of January 2024.
Each local NHS Health Board has the ability to develop bespoke local pharmacy services to suit the needs of local communities and patients
This Circular provides updated guidance aimed at both community optometry and community pharmacy teams and an updated referral form for the assessment and treatment of minor eye conditions.
The NHS Pharmacy First Scotland service has an annualised pool of £30.800m. The service will remunerate contractors for making the service available to their communities (Base element) and for the episodes of care provided in line with service (Activity element).
Circular PCA(P)(2020)16 set out the intention to introduce a combined National Foundation Programme and Independent Prescriber (IP) Career Pathway for community pharmacists.
Patient Group Directions (PGDs) that are to be added to the NHS Pharmacy First Scotland service for the treatment of seasonal allergic rhinitis (hay fever).
This Circular advises Health Boards and community pharmacy contractors of updated Patient Group Directions (PGDs) that are to be implemented for the treatment of urinary tract infections (UTI) and impetigo under NHS Pharmacy First Scotland.
As part of a move to a regional formulary review process in the East of Scotland, both NHS Lothian and NHS Borders will very shortly inform contractors that the dose of Flucloxacillin permitted
Our colleagues in Primary Care have highlighted the attached website as a source of information for professionals and patients which you may find useful in your practice, and Pharmacy First and First Plus in particular.
Circular PCA(P)(2021)5 set out the arrangements for the settlement for pharmaceutical services for the period 2020-21, including for NHS Pharmacy First Scotland.
Since its launch in the midst of the pandemic, you and your teams have supported the people of Scotland with their minor health conditions over 2 million times!
With the Revised List of Approved List Products (PCA (P) (2021) 14) Circular, from 1st October 2021
This Circular encloses a revised Approved List of Products for the NHS Pharmacy First Scotland service, which will come into force from 1st October 2021.
With the changes to the payment structure for both the Gluten Free Food Service and Unscheduled Care as of the 2021-22 financial framework.
Circular PCA(P)(2021)07 advises that Patient Group Directions (PGDs) supporting two further common clinical conditions will be added to the NHS Pharmacy First Scotland service.
This Circular provides information for community optometry teams about the NHS Pharmacy First Scotland (NHS PFS) service. It also provides guidance aimed at both community optometry and community pharmacy teams and a referral form for the assessment and treatment of minor eye conditions.
This circular informs NHS Boards and community pharmacy contractors of the intention to establish a combined National Foundation Programme and Independent Prescriber (IP) Career Pathway for community pharmacists.
On 24 March 2020, Scottish Government announced support to self-isolate to those at a very high risk of severe illness from COVID-19. This includes providing help to access medicines and food supplies. An extension to this shielding period to at least 31 July 2020 was further announced on 8 June 2020.
This circular encloses amendments to the Health Board Additional Pharmaceutical Services (Minor Ailment Service (Scotland) Directions 2016 for the Minor Ailment Service (MAS) in respect of eligibility for the service, which come into effect on 1 April 2020
This Circular advises community pharmacy contractors and NHS Boards of a one-off payment available to community pharmacy contractors to cover the completion of e-learning modules for the roll-out of the new NHS Pharmacy First Scotland service.
Community Pharmacy Scotland is delighted to highlight this report into the ART (Advice, Referral and Treatment) of pharmacy within the community setting.
Community Pharmacy Scotland (CPS) invites you to take part in our 2024 Communication Survey. Your feedback is essential in helping us improve our services.